Author Title [ Type(Desc)] Year
Filters: Author is Kapoor, Prashant  [Clear All Filters]
Journal Article
Sidana, S., M Sidiqi, H., Dispenzieri, A., Buadi, F.K., Lacy, M.Q., Muchtar, E., Dingli, D., Hayman, S.R., Gonsalves, W.I., Kapoor, P., et al. (2019). 15 Year Overall Survival Rates after Autologous Stem Cell Transplantation for AL Amyloidosis.Am J Hematol.
M Sidiqi, H., Aljama, M.A., Muchtar, E., Buadi, F.K., Warsame, R., Lacy, M.Q., Dispenzieri, A., Dingli, D., Leung, N., Gonsalves, W.I., et al. (2018). Autologous stem cell transplant for AL amyloidosis patients aged 70 to 75.Biol Blood Marrow Transplant.
Cordes, S., Gertz, M.A., Buadi, F.K., Lin, Y., Lacy, M.Q., Kapoor, P., Kumar, S.K., McCurdy, A., Dispenzieri, A., Dingli, D., et al. (2015). Autologous stem cell transplantation in immunoglobulin light chain amyloidosis with factor X deficiency.Blood Coagul Fibrinolysis.
Kilari, D., D'Souza, A., Fraser, R., Qayed, M., Davila, O., Agrawal, V., Díaz, M.Ángel, Chhabra, S., Cerny, J., Copelan, E., et al. (2019). Autologous Transplantation for Male Germ Cell Tumors: Improved Outcomes over 3 decades.Biol Blood Marrow Transplant.
Muchtar, E., Dispenzieri, A., Kumar, S.K., Dingli, D., Lacy, M.Q., Buadi, F.K., Hayman, S.R., Kapoor, P., Leung, N., Chakraborty, R., et al. (2016). Immunoparesis status in AL amyloidosis at diagnosis affects response and survival by regimen type.Haematologica.
Hwa, Y.L., Kumar, S.K., Gertz, M.A., Lacy, M.Q., Buadi, F.K., Kourelis, T.V., Gonsalves, W.I., S Rajkumar, V., Go, R.S., Leung, N., et al. (2016). Induction Therapy Pre-Autologous Stem Cell Transplantation in Immunoglobulin Light Chain Amyloidosis: A Retrospective Evaluation.Am J Hematol.
Kourelis, T.V., Kumar, S.K., Srivastava, G., Gertz, M.A., Lacy, M.Q., Buadi, F.K., Hayman, S.R., Zeldenrust, S.R., Leung, N., Kyle, R.A., et al. (2013). Long-term disease control in patients with newly diagnosed multiple myeloma after suspension of lenalidomide therapy.Am J Hematol.
Kourelis, T.V., Nasr, S.H., Dispenzieri, A., Kumar, S.K., Gertz, M.A., Fervenza, F.C., Buadi, F.K., Lacy, M.Q., Erickson, S.B., Cosio, F.G., et al. (2016). Outcomes of patients with renal monoclonal immunoglobulin deposition disease.Am J Hematol.
Hwa, Y.L., Gertz, M.A., Kumar, S.K., Lacy, M.Q., Buadi, F.K., Dingli, D., Kapoor, P., Zeldenrust, S.R., Leung, N., Hayman, S.R., et al. (2019). Prognostic restaging at the time of second-line therapy in patients with AL amyloidosis.Leukemia.
M Sidiqi, H., Aljama, M., Jevremovic, D., Muchtar, E., Buadi, F.K., Warsame, R., Lacy, M.Q., Dispenzieri, A., Dingli, D., Gonsalves, W.I., et al. (2018). Prognostic significance of stringent complete response post stem cell transplantation in AL amyloidosis.Biol Blood Marrow Transplant.
Mir, M.A., Kapoor, P., Kumar, S., Pandey, S., Dispenzieri, A., Lacy, M.Q., Dingli, D., Hogan, W., Buadi, F., Hayman, S., et al. (2015). Trends and Outcomes in Allogeneic Hematopoietic Stem Cell Transplant for Multiple Myeloma at Mayo Clinic.Clin Lymphoma Myeloma Leuk.